Zanidatamab, an Anti-HER2 Biparatopic that Induces Unique Surface HER2 Clusters and Complement-Dependent Cytotoxicity
Weisser, N., Wickman, G., Sanches, M., Escobar-Cabrera, E., O'Toole, J., Abraham, L., Guedia, J., Baichoo, P., Volkers, G., Schrag, J., Choi, K., Grothe, S., Baardsnes, J., Worrall, L.J., Atkinson, C.E., Harbourne, B., Cheng, C.W., Whalen, E., Smith, J., Zwierzchowski, P., Zwaagstra, J., Jolicoeur, N., Lippens, J., Fung, V., Black, S., Dargahi, D., Samiotakis, A., Chan, P., Stevens, C., Farber, P., Mukhopadhyay, A., Browman, D., Strynadka, N.C.J., Gold, M.R., Dixit, S.To be published.